Subtenon Block Combined With General Anesthesia for Vitreoretinal Surgery
NCT ID: NCT02282774
Last Updated: 2014-11-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
80 participants
INTERVENTIONAL
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia
NCT03902925
Effect of Warm Bupivacaine on Subtenon Block.
NCT07085481
Peribulbar Block for Prevention of Oculocardiac Reflex
NCT04549844
The Effect of Retrobulbar Block for Eye Surgery on Brain Oxygenation and Cognitive Functions in Elderly Patients
NCT03189329
Retrobulbar Block Versus Ketamine Infusion for Post-enucleation Analgesia
NCT03507426
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SB
receive subtenon block of 4mL of 2% lidocaine and 0.5% bupivacaine (50:50) mixture
2% lidocaine and 0.5% bupivacaine
Under general anesthesia and the operating microscope, a Lieberman lid speculum was placed and the conjunctiva was cleaned with 4% povidone iodine solution. The surgeon then created a fornix-based incision through conjunctiva and tenon's tissue inferonasally midway between the insertions of the medial and inferior rectus muscles, with blunt Wescott scissors to expose the scleral surface before tunneling posteriorly with curved Stevens scissors to create a small channel to the posterior subtenon space. A blunt-tipped subtenon cannula was then inserted into the posterior subtenon space, 4mL of 2% lidocaine and 0.5% bupivacaine (50:50) mixture versus saline was introduced and the drug solution was injected slowly into the subtenon space. After administration of local anesthetic mixture, the eyelid was gently taped down, and no ocular massage was performed
C
receive subtenon block of 4mL saline
Sham subtenon block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
2% lidocaine and 0.5% bupivacaine
Under general anesthesia and the operating microscope, a Lieberman lid speculum was placed and the conjunctiva was cleaned with 4% povidone iodine solution. The surgeon then created a fornix-based incision through conjunctiva and tenon's tissue inferonasally midway between the insertions of the medial and inferior rectus muscles, with blunt Wescott scissors to expose the scleral surface before tunneling posteriorly with curved Stevens scissors to create a small channel to the posterior subtenon space. A blunt-tipped subtenon cannula was then inserted into the posterior subtenon space, 4mL of 2% lidocaine and 0.5% bupivacaine (50:50) mixture versus saline was introduced and the drug solution was injected slowly into the subtenon space. After administration of local anesthetic mixture, the eyelid was gently taped down, and no ocular massage was performed
Sham subtenon block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* psychiatric conditions,
* neurological impairment,
* deafness with whom communication would be difficult in the postoperative period,
* clotting abnormalities,
* contraindications for regional anesthesia,
* drug abuse,
* history of allergy to the study drugs,
* previous vitreoretinal or strabismus surgery,
* endophthalmitis, or inflammatory eye pathology
* taking analgesics, antiemetics or drugs that might affect hemodynamics
40 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
King Saud University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwan Abouammoh
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marwan Abouammoh, MD
Role: PRINCIPAL_INVESTIGATOR
King Saud University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Abdulaziz University Hospital at King Saud University
Riyadh, Riyadh Region, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-13-968
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.